In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions.

Novavax is slimming down again by striking a deal to transfer the lease to its Maryland corporate headquarters to AstraZeneca in exchange for nearly $60 million. | Novavax will remain headquartered at ...

The head of the NC Pharmacy Board explains what it takes after all the federal guideline shifts to get a vaccine from your ...

Shah Capital renews pressure on Novavax board, saying the biotech’s underperformance calls for a strategic sale to unlock ...

Alongside the new COVID-19 vaccination guidelines, the CDC has made adjustments to its recommendations for toddler ...

GAITHERSBURG, Md., Aug. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration has approved the Nuvaxovid™ 2025-2026 Formula for the ...

AstraZeneca followed the blueprint of a deal Pfizer recently cut with the White House. Elsewhere, Novo is shuttering its cell ...

It’s that time of year when the leaves are turning golden, there’s a chill in the air and the threat of respiratory viruses ...

Novavax Inc on Tuesday delayed the start of a late-stage U.S. trial of its experimental coronavirus vaccine by roughly a month to the end of November, citing delays in scaling up the manufacturing ...

Amid confusion over this year's updated COVID-19 vaccines, we explain what's different this year and who experts say should ...